CYAD - Celyad Oncology

-

$undefined

N/A

(N/A)

Celyad Oncology NASDAQ:CYAD

Location: Axis Business Park Rue Edouard Belin 2, Brabant Wallon, 1435, Belgium | Website: https://www.celyad.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Short % of Float

0.96%

Insider Ownership

0.05%

Institutional Own.

29.16%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
CYAD-01 Details
Cancer, Acute myeloid leukemia, Blood cancer, Myelodysplastic syndrome, Multiple myeloma

Failed

Discontinued

CYAD-231 (NKG2DL) Details
Solid tumor/s, Cancer

Failed

Discontinued

CYAD-221 (CD19) Details
B-cell malignancies, Diffuse large B cell lymphoma, Cancer

Failed

Discontinued

CYAD-02 (NKG2DL) Details
Myelodysplastic syndrome, Blood cancer, Acute myeloid leukemia, Cancer

Failed

Discontinued

CYAD-211 (BCMA) Details
Multiple myeloma, Cancer

Failed

Discontinued

CYAD-101 Details
Metastatic colorectal cancer, Cancer

Failed

Discontinued

CYAD-103 (NKG2DL) Details
Solid tumor/s, Cancer

Failed

Discontinued